Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mukhametshina, Guzel Z
25  Ergebnisse:
Personensuche X
?
1

Efficacy and safety of nurulimab+prolgolimab with continued..:

Samoylenko, Igor V. ; Demidov, Lev V. ; Moiseenko, Fedor V....
Journal of Modern Oncology.  25 (2023)  3 - p. 313-324 , 2023
Link: https://doi.org/10.26442..
 
?
2

Afatinib in EGFR TKI-naïve patients with locally advanced o..:

de Marinis, Filippo ; Laktionov, Konstantin K. ; Poltoratskiy, Artem...
Lung Cancer.  152 (2021)  - p. 127-134 , 2021
Link: https://doi.org/10.1016/..
 
?
3

The efficacy of the combination of eribulin and trastuzumab..:

Kovalenko, Elena I. ; Artamonova, Elena V. ; Karabina, Elena V....
Journal of Modern Oncology.  22 (2020)  1 - p. 53-59 , 2020
Link: https://doi.org/10.26442..
 
?
4

Randomized double-blind clinical trial comparing safety and..:

Alexeev, Sergey M. ; Khorinko, Andrey V. ; Mukhametshina, Guzel Z....
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

The potential of using eribulin in patients with breast can..:

Kolyadina, Irina V ; Bulavina, Irina S ; Petkau, Vladislav V...
Journal of Modern Oncology.  21 (2019)  2 - p. 17-24 , 2019
Link: https://doi.org/10.26442..
 
?
6

Efficacy and safety of eribulin in HER2-negative metastatic..:

Gorbunova, Vera A ; Kolyadina, Irina V ; Kovalenko, Elena I...
Journal of Modern Oncology.  21 (2019)  1 - p. 12-23 , 2019
Link: https://doi.org/10.26442..
 
?
7

Efficacy and safety of nurulimab+prolgolimab with continued..:

Igor V. Samoylenko ; Lev V. Demidov ; Fedor V. Moiseenko...
https://modernonco.orscience.ru/1815-1434/article/viewFile/624195/139984.  , 2023
Link: https://doi.org/10.26442..
 
?
8

Afatinib in EGFR TKI-naïve patients with locally advanced o..:

Filippo de Marinis ; Konstantin K. Laktionov ; Artem Poltoratskiy...
info:eu-repo/semantics/altIdentifier/pmid/33387727.  , 2021
Link: http://hdl.handle.net/23..
 
?
9

Randomized double-blind clinical trial comparing safety and..:

Sergey M. Alexeev ; Andrey V. Khorinko ; Guzel Z. Mukhametshina...
http://link.springer.com/article/10.1186/s12885-020-07247-9.  , 2020
Link: https://doi.org/10.1186/..
 
?
10

The efficacy of the combination of eribulin and trastuzumab..:

Elena I. Kovalenko ; Elena V. Artamonova ; Elena V. Karabina...
https://modernonco.orscience.ru/1815-1434/article/viewFile/34173/22585.  , 2020
Link: https://doi.org/10.26442..
 
?
11

Efficacy and safety of eribulin in HER2-negative metastatic..:

Vera A Gorbunova ; Irina V Kolyadina ; Elena I Kovalenko...
https://modernonco.orscience.ru/1815-1434/article/viewFile/33502/pdf.  , 2019
Link: https://doi.org/10.26442..
 
?
12

The potential of using eribulin in patients with breast can..:

Irina V Kolyadina ; Irina S Bulavina ; Vladislav V Petkau...
https://modernonco.orscience.ru/1815-1434/article/viewFile/33500/pdf.  , 2019
Link: https://doi.org/10.26442..
 
?
13

OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Che..:

Mitsudomi, T. ; Heymach, J.V. ; Reck, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S71-S72 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Efficacy and Safety of Eribulin in Combination with Trastuz..:

Kovalenko, Elena Igorevna ; Manzyuk, Ludmila ; Gorbunova, Vera Andreevna...
The Breast.  36 (2017)  - p. S54 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Clinical effectiveness and safety of olaparib in BRCA-mutat..:

Balmaña, Judith ; Fasching, Peter A. ; Couch, Fergus J....
Breast Cancer Research and Treatment.  204 (2023)  2 - p. 237-248 , 2023
Link: https://doi.org/10.1007/..
 
1-15